We are live on ! Find out more
ACM

ACT Capital Management Portfolio holdings

AUM $153M
This Fund
S&P 500
This Quarter Est. Return
-15.78%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$71.5M
AUM Growth
-$23M
Cap. Flow
-$2.06M
Cap. Flow %
-2.89%
Top 10 Hldgs %
68.62%
Holding
96
New
11
Increased
4
Reduced
26
Closed
18

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$5.13M
2
CVX icon
Chevron
CVX
+$2.64M
3
DVN icon
Devon Energy
DVN
+$2.48M
4
U icon
Unity
U
+$1.49M
5
ET icon
Energy Transfer Partners
ET
+$1.43M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$4.23M
2
ARWR icon
Arrowhead Research
ARWR
+$2.48M
3
SSYS icon
Stratasys
SSYS
+$1.74M
4
LNTH icon
Lantheus
LNTH
+$1.71M
5
AIRS icon
AirSculpt Technologies
AIRS
+$942K

Sector Composition

Rank Sector Weight
1 Healthcare 66.98%
2 Energy 21.36%
3 Technology 7.65%
4 Materials 1.27%
5 Communication Services 1.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSBR icon
26
Champions Oncology
CSBR
$73.6M
$500K 0.7%
62,500
– –
FANG icon
27
Diamondback Energy
FANG
$52.4B
$485K 0.68%
+4,000
New +$548K
ROKU icon
28
Roku
ROKU
$21.8B
$460K 0.64%
+5,600
New +$543K
QTEK
29
DELISTED
QualTek Services Inc. Class A Common Stock
QTEK
$444K 0.62%
300,000
-54,269
-15% -$106K
DOCN icon
30
DigitalOcean
DOCN
$14.6B
$414K 0.58%
10,000
-15,000
-60% -$669K
AWH
31
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$380K 0.53%
43,067
-23,600
-35% -$240K
ZETA icon
32
Zeta Global
ZETA
$6.75B
$328K 0.46%
72,500
– –
VIST icon
33
Vista Energy
VIST
$7.04B
$307K 0.43%
+41,500
New +$354K
CYPH
34
Cypherpunk Technologies Inc
CYPH
$78M
$305K 0.43%
26,500
– –
IMDX
35
Insight Molecular Diagnostics
IMDX
$161M
$297K 0.42%
16,500
– –
SURF
36
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$280K 0.39%
170,500
– –
FUBO icon
37
FuboTV Inc
FUBO
$314M
$272K 0.38%
9,167
-6,833
-43% -$318K
CRDF icon
38
Cardiff Oncology
CRDF
$74.3M
$265K 0.37%
120,600
– –
NTRA icon
39
Natera
NTRA
$39.3B
$248K 0.35%
7,000
-5,500
-44% -$204K
ONCT
40
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$233K 0.33%
10,500
-750
-7% -$16.7K
NGNE icon
41
Neurogene
NGNE
$718M
$205K 0.29%
9,950
– –
MDNA
42
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$173K 0.24%
149,070
-3,430
-2% -$3.67K
ADAP
43
DELISTED
Adaptimmune Therapeutics
ADAP
$153K 0.21%
90,000
– –
LTHM
44
DELISTED
Livent Corporation
LTHM
$136K 0.19%
+6,000
New +$154K
DPRO
45
Draganfly
DPRO
$161M
$122K 0.17%
5,400
– –
MRKR icon
46
Marker Therapeutics
MRKR
$19M
$117K 0.16%
35,440
– –
GRTS
47
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$115K 0.16%
47,500
– –
RYTM icon
48
Rhythm Pharmaceuticals
RYTM
$7.59B
$114K 0.16%
27,500
– –
AMZN icon
49
Amazon
AMZN
$2.94T
$106K 0.15%
1,000
-3,000
-75% -$375K
AUD
50
DELISTED
Audacy, Inc.
AUD
$92K 0.13%
97,500
– –
1
2
3 4

Similar funds

BCI
Blue Capital Inc Omaha, Nebraska $153M AUM 28.69% 1-Year Est. Return
APW
Atlantic Private Wealth Chapel Hill, North Carolina $153M AUM 15.75% 1-Year Est. Return
DAM
Doheny Asset Management Los Angeles, California $153M AUM 42.04% 1-Year Est. Return
BVC
Bright Valley Capital Hong Kong $153M AUM 16.24% 1-Year Est. Return
RHAM
Round Hill Asset Management Pasadena, California $153M AUM 6.67% 1-Year Est. Return
RFN
Redwood Financial Network Solon, Ohio $153M AUM 17.17% 1-Year Est. Return
SGM
Sellaronda Global Management New York $152M AUM 2.1% 1-Year Est. Return
HWM
Horizons Wealth Management Asheville, North Carolina $152M AUM 9.43% 1-Year Est. Return

ACT Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, ACT Capital Management held 96 positions worth $71.5M, down 24% from $94.5M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

ACT Capital Management's Q2 2022 filing shows 11 new, 4 increased, 26 reduced and 18 closed positions. Its largest new stake was ExxonMobil: 56,900 shares worth $4.87M. The largest sale was NVIDIA, an estimated $4.23M.

By sector, the portfolio is most concentrated in Healthcare at 67% of assets, down from 76% a quarter earlier, followed by Energy and Technology.

  • ACT Capital Management's largest Q2 2022 buy was ExxonMobil: 56,900 shares worth $4.87M.
  • ACT Capital Management added most to Chevron in Q2 2022, an estimated $2.64M increase.
  • ACT Capital Management's biggest Q2 2022 reduction was Arrowhead Research, cutting an estimated $2.48M.
  • ACT Capital Management fully exited NVIDIA in Q2 2022, selling an estimated $4.23M.
  • ACT Capital Management's ten largest holdings make up 69% of its $71.5M portfolio in Q2 2022.
  • ACT Capital Management opened 11 new positions and closed 18 in Q2 2022.
  • ACT Capital Management's portfolio value fell 24% quarter-over-quarter to $71.5M.

Based on ACT Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.